Carboplatin/Gemcitabine/Pembrolizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of carboplatin, gemcitabine and pembrolizumab that can be used for the treatment of recurrent and metastatic hormone receptor-negative, HER-2 (EGFR2; ErbB2)-negative and PD-L1-positive breast cancer.

**Synonyms:** - Carboplatin and Gemcitabine (GCb) and Pembrolizumab - Carboplatin-Gemcitabine-Pembrolizumab - Carboplatin-Gemcitabine-Pembrolizumab Regimen - Carboplatin/Gemcitabine Plus Pembrolizumab - Carboplatin/Gemcitabine Plus Pembrolizumab Regimen - Carboplatin/Gemcitabine/Pembrolizumab - Paraplatin/Gemzar/Keytruda